Ex vivo enzymatic treatment of aged CD4 T cells restores antigen-driven CD69 expression and proliferation in mice.
Declines in immune function have been associated with declines in the function of naïve CD4 T cells. In vitro studies of naïve CD4 T cells in TCR-specific transgenic AND mice have shown age-related defects in immunosynapse formation, activation, proliferation and cytokine production. Previous work has also documented age-related alteration in the glycosylation of surface proteins involved in TCR signaling, and shown that enzymatic treatments to remove specific surface glycoproteins can restore in vitro function in CD4 cells from aged mice. Here an adoptive transfer system shows that a large percentage of naïve CD4 T cells from old mice fail to express CD69 and expand in antigen-primed mice, but these declines in CD69 and expansion can be restored by ex vivo pretreatment of the T cells with the bacterial enzyme O-sialoglycoprotein endopeptidase (OSGE). OSGE treatment also repairs the age-dependent loss of CD69 expression after in vivo activation.
Garcia
Gonzalo G
GG
Department of Pathology, University of Michigan School of Medicine, USA. gonzola@umich.edu
Miller
Richard A
RA
D000375:Aging / Q000187:drug effects* / Q000276:immunology; D000818:Animals; D000941:Antigens / Q000276:immunology; D015703:Antigens, CD / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D006031:Glycosylation / Q000187:drug effects; D007108:Immune Tolerance / Q000187:drug effects; D037181:Lectins, C-Type / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D008213:Lymphocyte Activation / Q000187:drug effects; D008666:Metalloendopeptidases / Q000494:pharmacology*; D051379:Mice; D008822:Mice, Transgenic; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D000099192:CD69 Antigens
D000941:Antigens; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D037181:Lectins, C-Type; D008666:Metalloendopeptidases; D011948:Receptors, Antigen, T-Cell; D000099192:CD69 Antigens; C070738:O-sialoglycoprotein endopeptidase
J Exp Med. 1996 Nov 1;184(5):1891-900
8920876
Cell Immunol. 1998 Dec 15;190(2):91-100
9878110
J Gerontol A Biol Sci Med Sci. 1997 May;52(3):B137-45
9158547
J Exp Med. 2004 Dec 20;200(12):1613-22
15611289
Eur J Immunol. 2005 Feb;35(2):622-31
15668924
Immunol Rev. 1997 Dec;160:79-90
9476667
Immunol Rev. 1997 Dec;160:9-18
9476661
J Immunol. 1990 Sep 1;145(5):1295-302
1974562
J Immunol. 1992 Mar 1;148(5):1458-64
1371528
J Immunol. 2004 May 1;172(9):5194-9
15100256
J Immunol. 2007 Feb 1;178(3):1321-31
17237378
J Immunol. 2002 Nov 1;169(9):5021-7
12391217
J Immunol. 2001 Mar 1;166(5):3151-7
11207267
J Exp Med. 1999 Oct 4;190(7):1013-24
10510091
J Immunol. 1994 Feb 1;152(3):1228-36
8301128
Eur J Immunol. 2003 Dec;33(12):3464-72
14635057
Int Immunol. 2005 Aug;17(8):983-91
16000332
Immunology. 2006 Oct;119(2):187-94
16805788
Immunol Rev. 2005 Jun;205:94-103
15882347
Immunology. 2006 Oct;119(2):178-86
16805789
Mech Ageing Dev. 1997 Jun;96(1-3):181-96
9223120
J Cell Biochem. 1991 Aug;46(4):312-20
1684583
J Exp Med. 2005 Mar 21;201(6):845-51
15781577
Stem Cells. 1994 Sep;12(5):456-65
7804122